Re: 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies' by Mikulska et al.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Description
Keywords
Antigens, Surface, Biological Therapy, CD52 Antigen, Communicable Diseases, Consensus, Humans, Lymphocytes
Journal Title
Clin Microbiol Infect
Conference Name
Journal ISSN
1198-743X
1469-0691
1469-0691
Volume Title
25
Publisher
Elsevier BV
